Admission serum XXXX levels and the risk of @entity1576 .

@entity1 @entity4612 @entity1272 @entity1576 @entity1760
BACKGROUND: The association between admission serum @entity1760 ( @entity4612 ) levels and risk of @entity1576 ( @entity1576 ) in hospitalised @entity1 is limited. The aim of this study was to assess the risk of developing @entity1576 in all hospitalised @entity1 with various admission @entity4612 levels. METHODS: This is a single-center retrospective study conducted at a tertiary referral hospital. All hospitalised adult @entity1 who had admission @entity4612 available from January to December 2013 were analysed in this study. Admission @entity4612 was categorised based on its distribution into six groups (less than 1.5, 1.5-1.7, 1.7-1.9, 1.9-2.1, 2.1-2.3 and greater than 2.3 @entity4612 /dl). The primary outcome was in-hospital @entity1576 occurring after hospital admission. Logistic regression analysis was performed to obtain the odds ratio of @entity1576 of various admission @entity4612 levels using @entity4612 of 1.7-1.9 @entity4612 /dl as the reference group. RESULTS: Of 9780 @entity1 enrolled, @entity1576 occurred in 619 @entity1 (6.3%). The lowest incidence of @entity1576 was when serum @entity4612 within 1.7-1.9 @entity4612 /dl. A U-shaped curve emerged demonstrating higher incidences of @entity1576 associated with both @entity1272 (< 1.7) and hypermagnesemia (> 1.9). After adjusting for potential confounders, both @entity1272 (< 1.5 @entity4612 /dl) and hypermagnesemia (> 2.3 @entity4612 /dl) were associated with an increased risk of developing @entity1576 with odds ratios of 1.69 (95% CI: 1.19-2.36) and 1.40 (95% CI: 1.02-1.91) respectively. CONCLUSION: Both admission @entity1272 and hypermagnesemia were associated with an increased risk for in-hospital @entity1576 .
